Research on the SARS-CoV-2 virus, which causes the current outbreak of COVID-19, is a global endeavour. Several facilities within our collaboration have started research on SARS-CoV-2 virus and opened calls for rapid access to dedicated beamtime. First results have been achieved: the SARS-CoV-2 viral main protease structure has been determined at BESSY II. The protease represents a critical target for therapy, and the results of the measurement can offer a new basis for further development of specific antiviral treatments. Read more here.
A list of publications on SARS-CoV-2 by LEAPS members and other synchrotron and FEL facilities around the globe can be found at lightsources.org. This list is updated on a daily basis. Lightsources.org is the result of the collaboration between communicators from light source facilities around the world.
Scientists can apply for rapid access at the following facilities (only member facilities of LEAPS are mentioned). Please find current information about the facilities at their own websites through Consortium in our top menu.
MAX IV Laboratory in Sweden provides rapid access:
Soleil in France provides rapid access:
DESY in Germany offers rapid access to PETRA III beamlines:
Elettra Sincrotrone Trieste in Italy opens to remote access following beamlines: XRD1, XRD2, SISSI-BIO and MCX:
BESSY II at HZB in Germany provides fast track access to their instruments for issues of highest relevance.
Contact: Manfred Weiss, team leader of MX joint research group
ALBA Synchrotron in Spain offers a COVID-19 RAPID ACCESS on all beamlines:
SOLARIS Synchrotron in Poland gives access to its Cryo-Electron Microscope thanks to a CERIC-ERIC initiative: https://www.ceric-eric.eu/2020/03/10/covid-19-fast-track-access/
Swiss Light Source and Swiss FEL at PSI in Switzerland offer priority access to combating COVID-19:
Diamond Light Source in the United Kingdom opened also a call for rapid access: